Fig. 2From: Evaluation of a novel surface-coating formulation with time-extended antimicrobial activity for healthcare environment disinfectionLaboratory phase: antimicrobial capacity of the tested formulation expressed as log10 reduction of two tested drug-resistant ATCC reference bacterial strains inoculated onto OxiLast-coated PCV surfaces at various coating ages (days) and kept for 15 or 30 min contact time in presence of bovine serum albumin (BSA) 3 mg/ml. Error bars indicate standard deviationBack to article page